Search

Molecular biologist Dr. Vincent Tagliabracci is one of 60 researchers across the country selected for an award in a National Institutes of Health program supporting highly innovative science.

Leaders of UT Southwestern and Children’s Health came together Wednesday, Oct. 16, to celebrate an agreement to create a new venture to enhance pediatric care in North Texas.

The increasing sophistication of cancer treatments threatens to outpace the ability of health care providers to enroll patients in clinical trials to test those therapies. That’s a key finding by researchers in UT Southwestern’s new Department of Population and Data Sciences.

Dr. Joan S. Reisch has a saying: “I was born in Connecticut, grew up in Ohio, and moved to Texas … where I live happily ever after.” With a career spanning 60 years, she is currently a UT Southwestern Professor of Population and Data Sciences and Family and Community Medicine and a generous donor for prostate cancer research, in honor of her late husband.

Dr. Zhu’s research efforts have led to his appointment as the inaugural holder of the Kern Wildenthal, M.D., Ph.D. Distinguished Professorship in Pediatric Research. Dr. Wildenthal, President Emeritus, served as the second President of UT Southwestern from 1986-2008. Under his leadership, UT Southwestern more than quintupled in size and emerged as one of the leading medical institutions in the world.

A phase three clinical trial that UT Southwestern participated in determined that a three-drug combination improved lung function and reduced symptoms in cystic fibrosis (CF) patients who have a single copy of the most common genetic mutation for the disease.

Using artificial intelligence to identify patterns of brain activity that make people less responsive to certain antidepressants, two studies led by UT Southwestern provide evidence for the impact of biology.

UT Southwestern and Reimagine RedBird have signed an agreement for UT Southwestern to establish a new medical center, expanding health care services, and providing southern Dallas residents more convenient access to UT Southwestern’s best-in-class medical care in their own community.

Dr. Parsia Vagefi brought the new surgical protocol for bile duct cancer and liver disease when he came to UT Southwestern in 2018 as Associate Professor of Surgery and the Ernest Poulos, M.D. Distinguished Chair in Surgery. The surgery protocol would give Mr. Cueto a new liver by transplant and surgically remove the bile duct.

Leadership for UT Southwestern's Faculty Women's Club.